Insights into the Worldwide BRAF Mutated Non-Small Cell Lung Cancer (2018 to 2030) - Organize Sales and Marketing Efforts by Identifying the Best Opportunities

Source :: Plus Company Updates. May 14, 2020
Publication Year :: 2020
Abstract: Dublin: Research and Markets has issued the following press release: The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Subjects :: Dabrafenib -- Reports -- Forecasts and trends
Marketing -- Forecasts and trends -- Reports
Small cell lung cancer -- Forecasts and trends -- Reports
Trametinib -- Reports -- Forecasts and trends
Epidemiology -- Reports -- Forecasts and trends
Non-small cell lung cancer -- Reports -- Forecasts and trends
Lung cancer
Profits
Market trend/market analysis
General interest
News, opinion and commentary

Tools